Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+9.87%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$18.1B
AUM Growth
+$3.54B
(+24%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
12.39%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
1,123
New
357
Increased
247
Reduced
223
Closed
265
Top Buys
| 1 |
Palantir
PLTR
|
$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$234M |
| 3 |
Eli Lilly
LLY
|
$195M |
| 4 |
Meta Platforms (Facebook)
META
|
$194M |
| 5 |
CSX Corp
CSX
|
$140M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$345M |
| 2 |
Merck
MRK
|
$170M |
| 3 |
Canadian National Railway
CNI
|
$139M |
| 4 |
CrowdStrike
CRWD
|
$123M |
| 5 |
NXP Semiconductors
NXPI
|
$122M |
Sector Composition
| 1 | Healthcare | 24.05% |
| 2 | Technology | 22.07% |
| 3 | Consumer Discretionary | 14.65% |
| 4 | Financials | 9.65% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
State Street
STT
$32B
| $4.86M | 0.02% |
81,844
+78,700
| +2,503% | +$4.67M |
|
527
Boston Beer
SAM
$2.47B
| $4.84M | 0.02% |
5,478
+878
| +19% | +$776K |
|
528
Cintas
CTAS
$82.4B
| $4.83M | 0.02% |
+58,052
| New | +$4.83M |
|
529
Eagle Materials
EXP
$7.86B
| $4.81M | 0.02% |
+55,700
| New | +$4.81M |
|
530
Royal Caribbean
RCL
$95.7B
| $4.77M | 0.02% |
+73,686
| New | +$4.77M |
|
|
RCM
531
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.76M | 0.02% |
277,677
-385,197
| -58% | -$6.61M |
|
532
Aldeyra Therapeutics
ALDX
$334M
| $4.76M | 0.02% |
+641,918
| New | +$4.76M |
|
533
Seres Therapeutics
MCRB
$169M
| $4.71M | 0.02% |
+8,319
| New | +$4.71M |
|
534
Plains GP Holdings
PAGP
$3.64B
| $4.7M | 0.02% |
+771,853
| New | +$4.7M |
|
535
Prelude Therapeutics
PRLD
$69.6M
| $4.69M | 0.02% |
+155,690
| New | +$4.69M |
|
|
ENDP
536
DELISTED
Endo International plc
ENDP
| $4.68M | 0.02% |
+1,417,200
| New | +$4.68M |
|
537
Liberty Global Class A
LBTYA
$4.05B
| $4.62M | 0.02% |
+219,886
| New | +$4.62M |
|
538
Xylem
XYL
$34.2B
| $4.62M | 0.02% |
+54,900
| New | +$4.62M |
|
539
Smith & Nephew
SNN
$16.5B
| $4.58M | 0.02% |
117,091
+36,878
| +46% | +$1.44M |
|
540
Cal-Maine
CALM
$5.52B
| $4.53M | 0.02% |
+118,007
| New | +$4.53M |
|
541
Taysha Gene Therapies
TSHA
$917M
| $4.48M | 0.02% |
+200,000
| New | +$4.48M |
|
|
JKS
542
JinkoSolar
JKS
$1.32B
| $4.48M | 0.02% |
+112,631
| New | +$4.48M |
|
|
AMRN
543
Amarin Corp
AMRN
$317M
| $4.45M | 0.02% |
52,901
-2,531
| -5% | -$213K |
|
544
Akero Therapeutics
AKRO
$3.58B
| $4.41M | 0.02% |
143,139
-301,893
| -68% | -$9.29M |
|
545
NVR
NVR
$23.5B
| $4.38M | 0.02% |
1,073
-3,154
| -75% | -$12.9M |
|
546
Knight Transportation
KNX
$7B
| $4.36M | 0.02% |
+107,037
| New | +$4.36M |
|
|
GAN
547
DELISTED
GAN Ltd
GAN
| $4.35M | 0.02% |
257,292
+64,666
| +34% | +$1.09M |
|
548
Telefônica Brasil
VIV
$20.1B
| $4.34M | 0.02% |
+565,306
| New | +$4.34M |
|
549
Lam Research
LRCX
$130B
| $4.34M | 0.02% |
+130,660
| New | +$4.34M |
|
550
Mattel
MAT
$6.06B
| $4.33M | 0.02% |
+369,949
| New | +$4.33M |
|